{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:22:11Z","timestamp":1790799731811,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.vaccine.2009.09.033","type":"journal-article","created":{"date-parts":[[2009,11,18]],"date-time":"2009-11-18T14:08:56Z","timestamp":1258553336000},"page":"7198-7201","source":"Crossref","is-referenced-by-count":46,"title":["Poxvirus-vectored vaccines for rabies\u2014A review"],"prefix":"10.1016","volume":"27","author":[{"given":"Jacqueline","family":"Weyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis H.","family":"Nel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.09.033_bib1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0923-2516(89)80126-8","article-title":"Risks and benefits of vaccinia vaccine use in the worldwide smallpox eradication campaign","volume":"140","author":"Fenner","year":"1989","journal-title":"Res Virol"},{"key":"10.1016\/j.vaccine.2009.09.033_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0378-1119(83)90163-4","article-title":"Infectious poxvirus vectors have capacity for at least 25000 base pairs of foreign DNA","volume":"25","author":"Smith","year":"1983","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2009.09.033_bib3","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1126\/science.2992092","article-title":"Recombinant vaccinia virus: immunization against multiple pathogens","volume":"229","author":"Perkus","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2009.09.033_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0147-9571(03)00019-5","article-title":"Poxviruses as vaccine vectors","volume":"26","author":"Pastoret","year":"2003","journal-title":"Comp Immunol Micro Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.033_bib5","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.79.23.7415","article-title":"A selectable eukaryotic cloning and expression vector","volume":"79","author":"Mackett","year":"1982","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.09.033_bib6","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1016\/j.vaccine.2006.11.066","article-title":"Development and registration of recombinant veterinary vaccines, the example of the canarypox vector platform","volume":"25","author":"Poulet","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.033_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/312163a0","article-title":"Expression of rabies virus glycoprotein from a recombinant vaccinia virus","volume":"312","author":"Kieny","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2009.09.033_bib8","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1073\/pnas.81.22.7194","article-title":"Protection from rabies by vaccinia virus recombinant containing the rabies virus glycoprotein","volume":"81","author":"Wiktor","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6077","key":"10.1016\/j.vaccine.2009.09.033_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/322373a0","article-title":"Oral vaccination of fox against rabies using a live recombinant vaccinia virus","volume":"322","author":"Blancou","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2009.09.033_bib10","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.1073\/pnas.83.20.7947","article-title":"Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine","volume":"83","author":"Rupprecht","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.09.033_bib11","first-page":"173","article-title":"Oral immunization of wildlife against rabies: opportunities and challenges in prevention and control","volume":"119","author":"Rupprecht","year":"2004","journal-title":"Dev Biol"},{"key":"10.1016\/j.vaccine.2009.09.033_bib12","series-title":"Recombinant poxviruses","first-page":"163","article-title":"Development and deliberate release of a vaccinia-rabies recombinant virus for the oral vaccination of foxes against rabies","author":"Pastoret","year":"1992"},{"key":"10.1016\/j.vaccine.2009.09.033_bib13","first-page":"185","article-title":"Elimination of terrestrial rabies in Western European countries","volume":"119","author":"Cliquet","year":"2004","journal-title":"Dev Biol (Basel)"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.033_bib14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.7589\/0090-3558-38.3.539","article-title":"Vaccination of vampire bats using recombinant vaccinia-rabies virus","volume":"38","author":"Aguilar-Seti\u00e9n","year":"2002","journal-title":"J Wild Dis"},{"key":"10.1016\/j.vaccine.2009.09.033_bib15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.7589\/0090-3558-43.1.124","article-title":"Rabies challenge of captive striped skunks (Mephitis mephitits) following oral administration of a live vaccinia-vectored rabies vaccine","volume":"43","author":"Grosenbaugh","year":"2007","journal-title":"J Wild Dis"},{"key":"10.1016\/j.vaccine.2009.09.033_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.virusres.2005.03.017","article-title":"Oral vaccination of dogs with recombinant rabies virus vaccines","volume":"111","author":"Rupprecht","year":"2005","journal-title":"Virus Res"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.033_bib17","doi-asserted-by":"crossref","first-page":"540","DOI":"10.7589\/0090-3558-25.4.540","article-title":"Use of recombinant vaccinia-rabies glycoprotein for oral vaccination of wildlife against rabies: innocuity to several non-target bait consuming species","volume":"25","author":"Brochier","year":"1989","journal-title":"J Wildl Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.033_bib18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0264-410X(96)00163-6","article-title":"A recombinant vaccinia virus in the immunocompromised host: oral innocuity, progressive parenteral infection and therapeutics","volume":"15","author":"Hanlon","year":"1997","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2009.09.033_bib19","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1056\/NEJMoa010560","article-title":"Human infection due to recombinant vaccinia-rabies glycoprotein virus","volume":"345","author":"Rupprecht","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.09.033_bib20","series-title":"Genetically engineered organisms: assessing environmental and human health effects","first-page":"331","article-title":"Environmental risks of genetically engineered vaccines","author":"Traavik","year":"2002"},{"issue":"9","key":"10.1016\/j.vaccine.2009.09.033_bib21","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1128\/JCM.36.9.2542-2547.1998","article-title":"Naturally occurring orthopoxviruses: potential for recombination with vaccine vectors","volume":"36","author":"Sandvik","year":"1998","journal-title":"J Clin Microb"},{"key":"10.1016\/j.vaccine.2009.09.033_bib22","doi-asserted-by":"crossref","first-page":"11341","DOI":"10.1073\/pnas.93.21.11341","article-title":"Genetically engineered poxviruses for recombinant gene expression, vaccination and safety","volume":"93","author":"Moss","year":"1996","journal-title":"Proc Nat Acad Sci USA"},{"issue":"8807","key":"10.1016\/j.vaccine.2009.09.033_bib23","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/0140-6736(92)92027-D","article-title":"Immunization with canarypox virus expressing rabies glycoprotein","volume":"339","author":"Cadoz","year":"1992","journal-title":"The Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.033_bib24","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0264-410X(95)00171-V","article-title":"Human safety and immunogenicity of canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system","volume":"14","author":"Fries","year":"1996","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.033_bib25","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2460\/javma.228.5.726","article-title":"Protection from challenge following administration of canarypox virus-vectored recombinant feline leukaemia virus vaccine in cats previously vaccinated with a killed virus vaccine","volume":"228","author":"Grosenbaugh","year":"2006","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2009.09.033_bib26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2174\/1568005033481123","article-title":"Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery","volume":"3","author":"Sutter","year":"2003","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.vaccine.2009.09.033_bib27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/viro.1998.9123","article-title":"The complete genomic sequence of the modified vaccinia virus Ankara strain: comparison with other orthopoxviruses","volume":"244","author":"Antoine","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2009.09.033_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.copbio.2004.09.001","article-title":"Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?","volume":"15","author":"Drexler","year":"2004","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.vaccine.2009.09.033_bib29","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","article-title":"Nonreplicating vaccinia vector efficiently expresses recombinant genes","volume":"89","author":"Sutter","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.09.033_bib30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/viro.1997.8845","article-title":"Host range and cytopathogenicity of highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line","volume":"238","author":"Carroll","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2009.09.033_bib31","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1016\/j.vaccine.2007.02.084","article-title":"Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies","volume":"25","author":"Weyer","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.033_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0034-5288(18)30655-6","article-title":"A single vaccine for the control of capripox infection in sheep and goats","volume":"42","author":"Kitching","year":"1987","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2009.09.033_bib33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-3-662-39771-8_3","article-title":"Lumpy skin disease virus","volume":"3","author":"Weiss","year":"1968","journal-title":"Virol Monog"},{"issue":"7","key":"10.1016\/j.vaccine.2009.09.033_bib34","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0264-410X(93)90258-Y","article-title":"Single capripox recombinant vaccine for the protection of cattle against rinderpest and lumpy skin disease","volume":"11","author":"Romero","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.033_bib35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1006\/viro.1994.1548","article-title":"Recombinant capripoxvirus expressing the haemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease","volume":"204","author":"Romero","year":"1994","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.033_bib36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0264-410X(95)80008-2","article-title":"Protection of goats against peste des petits ruminants with recombinant capripoxviruses expressing the fusion and haemagglutinin protein genes of rinderpest virus","volume":"13","author":"Romero","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.033_bib37","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/vr.135.7.152","article-title":"Protection of cattle against rinderpest and lumpy skin disease with a recombinant capripoxvirus expressing the fusion protein gene of rinderpest virus","volume":"135","author":"Romero","year":"1994","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2009.09.033_bib38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/viro.1996.0306","article-title":"Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripoxvirus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge","volume":"220","author":"Wade-Evans","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2009.09.033_bib39","first-page":"67","article-title":"Trail of capripoxvirus-rinderpest recombinant vaccine in African cattle","volume":"118","author":"Ngicabe","year":"1997","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2009.09.033_bib40","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1128\/JVI.77.2.1571-1577.2003","article-title":"Development of a dual recombinant vaccine to protect small ruminant against peste-des-petits-ruminants virus and capripoxvirus infections","volume":"77","author":"Berhe","year":"2003","journal-title":"J Virol"},{"issue":"23","key":"10.1016\/j.vaccine.2009.09.033_bib41","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.vaccine.2004.10.006","article-title":"Immune responses to recombinants of South African vaccine strain of lumpy skin disease generated b using thymidine kinase gene insertion","volume":"23","author":"Wallace","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.033_bib42","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1016\/S0264-410X(02)00203-7","article-title":"Immunogenicity of a recombinant lumpy skin disease virus (Neethling vaccine strain) expressing the rabies virus glycoprotein in cattle","volume":"20","author":"Aspden","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.033_bib43","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1099\/vir.0.19116-0","article-title":"Evaluation of lumpy skin disease virus, a capripoxvirus, as a replication-deficient vaccine vector","volume":"84","author":"Aspden","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2009.09.033_bib44","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2004","journal-title":"Bull WHO"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.033_bib45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.virusres.2005.03.006","article-title":"Overview of rabies in the Americas","volume":"111","author":"Belotto","year":"2005","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2009.09.033_bib46","first-page":"189","article-title":"Epidemiology of rabies in Southeast Europe","volume":"131","author":"Johnson","year":"2008","journal-title":"Dev Biol (Basel)"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.033_bib47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vetmic.2006.04.009","article-title":"Canine vaccination\u2014providing broader benefits for disease control","volume":"117","author":"Cleaveland","year":"2006","journal-title":"Vet Microbiol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.09.033_bib48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.virusres.2008.11.004","article-title":"Molecular epidemiology of rabies: focus on domestic dogs (Canis familiaris) and black-backed jackals (Canis mesomelas) from northern South Africa","volume":"140","author":"Zulu","year":"2009","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2009.09.033_bib49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1746-6148-2-2","article-title":"A molecular epidemiological study of rabies epizootics in kudu (Tragelaphus strepsiceros) in Namibia","volume":"2","author":"Mansfield","year":"2006","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.vaccine.2009.09.033_bib50","unstructured":"Weyer J. Immune responses to recombinant poxvirus vaccines expressing full length lyssavirus glycoprotein genes. PhD thesis, University of Pretoria; 2006, p. 63\u201371."},{"key":"10.1016\/j.vaccine.2009.09.033_bib51","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.vaccine.2007.11.029","article-title":"Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies","volume":"26","author":"Zhang","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.033_bib52","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0264-410X(96)00012-6","article-title":"Human adenovirus type 5 vectors expressing rabies glycoprotein","volume":"14","author":"Yarosh","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.033_bib53","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1016\/j.vaccine.2009.02.074","article-title":"In vitro and in vivo genetic stability studies of a human adenovirus type 5 recombinant rabies glycoprotein vaccine (ONRAB)","volume":"27","author":"Knowles","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.033_bib54","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1586\/14760584.2.3.399","article-title":"New approaches to the prevention and eradication of rabies","volume":"2","author":"Dietzschold","year":"2003","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2009.09.033_bib55","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.virol.2006.07.037","article-title":"A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice","volume":"356","author":"Li","year":"2006","journal-title":"Virology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09013577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09013577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T19:06:24Z","timestamp":1590260784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09013577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":55,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0264410X09013577"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.09.033","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}